optimal). The magnitude of the response will increase the greater the molecular
weight. If an antibody is to be made to a molecule smaller than 2 000 Da then it has
to be conjugated to a carrier molecule to effectively increase its size above the
threshold for immune surveillance. These small molecules are known ashaptens
and may be peptides, organic molecules or other small chemicals. They are usually
conjugated to a protein such as albumin, keyhole limpet haemocyanin or thyroglo-
bulin and then used to immunise animals for antibody production (Fig. 7.7). If a
polyclonal antibody is being made it is advisable to change the carrier protein at least
once in the immunisation procedure as this favours more antibody being made to the
hapten and less to each of the carrier proteins. If a monoclonal antibody is being made
then the carrier protein can be the same throughout the immunisations. When
screening hybridomas for monoclonal antibody production it is necessary to screen
against the hapten and carrier separately. Any antibodies responding to both should
be discarded as these will be recognising the junction between the hapten and carrier
and will not recognise the native hapten.
Hybridoma
cell line
Clone cells
ELISA test then
choose one
clone to expand
12 simultaneous
freezings for
master cell bank
Thaw last
freezing and
grow cells
50 simultaneous
freezings for
working cell bank
Fig. 7.6Master and working cell banks.
278 Immunochemical techniques